Bone Mineral Density Assessment

BMD Basics - Density Deep Dive

• Bone Mineral Density (BMD): Areal density of bone mineral ($g/cm^2$). Key indicator of bone strength & fracture risk.
• Gold Standard: Dual-energy X-ray absorptiometry (DEXA/DXA).
• T-score: BMD vs. young, healthy, sex-matched adult mean (peak bone mass).
  • Normal: ≥ -1.0 SD
  • Osteopenia: < -1.0 to > -2.5 SD
  • Osteoporosis: ≤ -2.5 SD
  • Severe: Osteoporosis + ≥1 fragility fracture.
• Z-score: BMD vs. age-, sex-matched peers. For premenopausal women, men <50 yrs, children.

⭐ A T-score of -2.5 SD or lower is diagnostic of osteoporosis in postmenopausal women and men aged 50 and older.

Indications - Scan Signals

• Universal Screening:
  • Women ≥ 65 years
  • Men ≥ 70 years
• Risk-Based Screening (Younger Individuals):
  • Postmenopausal women < 65 yrs with risk factors
  • Men aged 50-69 yrs with risk factors
• Specific High-Risk Conditions/Factors:
  • Fragility fracture (adults >50 yrs)

  ⭐ Glucocorticoid therapy (≥ 5 mg prednisone/day or equivalent for ≥ 3 months) is a critical indication.

  • Low body weight (BMI < 19 kg/m²) or significant weight loss (>10%)
  • Parental history of hip fracture
  • Medical conditions: RA, hypogonadism, hyperparathyroidism, IBD
  • Lifestyle: Current smoking, high alcohol intake (>3 units/day)
• Other Clinical Scenarios:
  • Radiographic osteopenia or vertebral deformity
  • Monitoring response to osteoporosis therapy
  • Before initiating pharmacologic therapy for osteoporosis

DXA Deconstructed - Pixel Perfect PEEK

• Principle: Measures Bone Mineral Density (BMD) using dual X-ray beams.
• Key Sites:
  • Lumbar spine (L1-L4)
  • Hip (total, femoral neck)
  • Forearm (distal radius): if spine/hip unusable or in hyperparathyroidism.
• Scores & Interpretation:
  • T-score: BMD vs. young adult (sex-matched).
    • Normal: T-score $\ge \textbf{-1.0}$
    • Osteopenia: T-score between $\textbf{-1.0}$ and $\textbf{-2.5}$
    • Osteoporosis: T-score $\le \textbf{-2.5}$
    • Severe Osteoporosis: T-score $\le \textbf{-2.5}$ + fragility fracture.
  • Z-score: BMD vs. age-matched (premenopausal women, men <50y, children).
    • $\le \textbf{-2.0}$: "Below expected range for age".
• Pros: Gold standard, low radiation, precise.
• Cons: Artifacts (osteophytes, vertebral #, calcification) affect accuracy.

⭐ A T-score of -2.5 or lower at key sites (spine, total hip, femoral neck) diagnoses osteoporosis.

T-Scores & Z-Scores - Decoding Density

• T-Score: BMD vs. young adult (same sex). For postmenopausal women & men >50 yrs.
  • Normal: ≥ -1.0 SD
  • Osteopenia: -1.0 to -2.5 SD
  • Osteoporosis: ≤ -2.5 SD
  • Severe: ≤ -2.5 SD + fragility fracture
• Z-Score: BMD vs. age-sex-ethnicity matched peers. For premenopausal women, men <50 yrs, children.
  • ≤ -2.0 SD: "Below expected range for age"; investigate secondary causes.

  • -2.0 SD: "Within expected range for age".

⭐ T-score is key for diagnosing osteoporosis in postmenopausal women and men >50 years.

FRAX & Follow-Up - Crystal Ball BMD

• FRAX: 10-yr major osteoporotic & hip fracture probability.
  • Uses Clinical Risk Factors (CRFs) ± BMD.
  • Key CRFs: Age, BMI, prior fracture, steroids, parental hip fracture, smoking, alcohol.
• Intervention: Based on country-specific FRAX thresholds (e.g., major ≥20%, hip ≥3%).
• Follow-Up:
  • BMD check: 1-2 yrs post-therapy initiation.
  • Stable/low risk: BMD every 2-5 yrs.
  • Bisphosphonates: Consider drug holiday after 3-5 yrs.

⭐ FRAX is primarily for treatment-naive individuals to guide decisions on initiating therapy.

High‑Yield Points - ⚡ Biggest Takeaways

• DEXA (Dual-energy X-ray absorptiometry) is the gold standard for BMD assessment.
• T-score: Compares patient's BMD to young, healthy, sex-matched adults.
• Z-score: Compares patient's BMD to age, sex, and ethnicity-matched peers.
• WHO diagnostic criteria for osteoporosis: T-score ≤ -2.5 SD; Osteopenia: T-score -1.0 to -2.5 SD.
• Preferred DEXA sites: lumbar spine (L1-L4), hip (femoral neck/total hip).
• FRAX tool calculates 10-year probability of major osteoporotic fracture.
• Quantitative Ultrasound (QUS) of the calcaneus is a portable screening tool, not for definitive diagnosis of osteoporosis.